Adjunctive Skin Care of the Brow and Periorbital Region

Clinics in Plastic Surgery

Volumn 40, Issue 1, 2013, Pages 225-236

  Bucay, Vivian W ^a   Day, Doris ^b,c  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Day Dermatology and Aesthetics   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anti aging cosmeceuticals; Antioxidants; Brow; Growth factors; Peptides; Periorbital; Retinoids; Skin care

Indexed keywords

4 METHOXYCINNAMIC ACID 2 ETHYLHEXYL ESTER; ALPHA TOCOPHEROL; ANTHRANILIC ACID METHYL ESTER; ANTIOXIDANT; ASCORBIC ACID; AVOBENZONE; BENZOPHENONE; CAMELLIA SINENSIS EXTRACT; COLLAGEN; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; HOMOSALATE; ICHTHAMMOL; INTERSTITIAL COLLAGENASE; IRON OXIDE; KAOLIN; NICOTINAMIDE; NON PRESCRIPTION DRUG; OXYBENZONE; PLANT EXTRACT; PLATELET DERIVED GROWTH FACTOR; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; REACTIVE OXYGEN METABOLITE; RETINOID; SOMATOMEDIN; SUNSCREEN; TITANIUM DIOXIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULOTROPIN; ZINC OXIDE;

AGING; CONTACT DERMATITIS; ESTHETIC SURGERY; EYEBROW; EYELASH; HUMAN; IRRITANT DERMATITIS; MEDICINAL PLANT; MINIMALLY INVASIVE PROCEDURE; ORBIT; PHOTOSENSITIVITY DISORDER; REJUVENATION; REVIEW; SKIN ALLERGY; SKIN CARE; SKIN PROTECTION; SURGICAL TECHNIQUE; TEA; ULTRAVIOLET RADIATION; WRINKLE;

ANTIOXIDANTS; COSMETICS; EYEBROWS; EYELASHES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; ORBIT; PEPTIDES; REJUVENATION; RETINOIDS; SKIN AGING; SKIN CARE; SUNSCREENING AGENTS;

EID: 84870156542     PISSN: 00941298     EISSN: 15580504     Source Type: Journal    
DOI: 10.1016/j.cps.2012.09.003     Document Type: Review

References (82)

1. Hanneman K.K., Cooper K.D., Baron E.D. Ultraviolet immunosuppression: mechanisms and consequences. Dermatol Clin 2006, 24(1):19-25.
2. Sunscreen drug products for over-the-counter use; final monograph. Food and Drug Administration, HHS. Final rule. Fed Regist 1999, 64(98):27666-27693.
3. Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol 1956, 11:298-300.
4. Greenstock C.L. Free radicals, aging and degenerative diseases 1986, Alan R. Liss, Inc, New York.
5. Cohen R.M., Pinnell S.R. Topical vitamin C in aging. Clin Dermatol 1996, 14:227-234.
6. Lin J.Y., Selim M.A., Shea C.R., et al. UV Photoprotection by combination topical antioxidants vitamins C and E. J Am Acad Dermatol 2003, 48:866-874.
7. Humbert P.G., Haftek M., Creidi P., et al. Topical ascorbic acid in photoaged skin. Clinical topographical and ultrastructural evaluation: double-blind study vs. placebo. Exp Dermatol 2003, 12(3):237-244.
8. Traikovich S.S. Use of topical ascorbic acid and its effects on photodamaged skin topography. Arch Otolaryngol Head Neck Surg 1999, 125(10):1091-1098.
9. Fitzpatrick R.E., Rostan E.F. Topical vitamin C for photodamage. Dermatol Surg 2002, 28(3):231-236.
10. Barnet Products Corp Stable forms of vitamin C. Technical bulletin 2001, Barnet Products Corp, Englewood Cliffs (NJ).
11. Geesin J.C., Darr D., Kaufman R., et al. Ascorbic acid specifically increases type I and type III procollagen messenger RNA levels in human skin fibroblast. J Invest Dermatol 1988, 90(4):420-424.
12. McCay P.B. Vitamin E: interaction with free radicals and ascorbate. Annu Rev Nutr 1985, 5:323-340.
13. Chan A.C. Partners in defense, vitamin E and vitamin C. Can J Physiol Pharmacol 1993, 71:725-731.
14. Trevithick J.R., Xiong H., Lee S., et al. Topical tocopherol acetate reduces post-UVB, sunburn-associated erythema, edema, and skin sensitivity in hairless mice. Arch Biochem Biophys 1992, 296(2):575-582.
15. Gensler H.L., Magadaleno M. Topical vitamin E inhibition of immunosuppression and tumorigenesis induced by ultraviolet irradiation. Nutr Cancer 1991, 15(2):97-106.
16. Kagan V.E. Tocopherol stabilizes membrane against phospholipase A, free fatty acids, and lysophospholipids. Ann N Y Acad Sci 1989, 570:121-135.
17. Chung J.H., Seo J.Y., Lee M.K., et al. Ultraviolet modulation of human macrophage metalloelastase in human skin in vivo. J Invest Dermatol 2002, 119(2):507-512.
18. Mayer P. The effects of vitamin E on the skin. Cosmet Toiletries 1993, 108:99.
19. Katiyar S.K., Ahmad N., Mukhtar H. Green tea and skin. Arch Dermatol 2000, 136(8):989-994.
20. Wang Z.Y., Agarwal R., Bickers D.R., et al. Protection against ultraviolet B radiation-induced photocarcinogenesis in hairless mice by green tea polyphenols. Carcinogenesis 1991, 12(8):1527-1530.
21. Vayalil P.K., Mittal A., Hara Y., et al. Green tea polyphenols prevent ultraviolet-induced oxidative damage and matrix metalloproteinases expression in mouse skin. J Invest Dermatol 2004, 122(6):1480-1487.
22. Elmets C.A., Singh D., Tubesing K., et al. Cutaneous photoprotection from ultraviolet injury by green tea polyphenols. J Am Acad Dermatol 2001, 44(3):425-432.
23. Katiyar S.K., Afaq F., Perez A., et al. Green tea polyphenol treatment to human skin prevents formation of ultraviolet light B-induced pyrimidine dimers in DNA. Clin Cancer Res 2000, 6:3864-3869.
24. Katiyar S.K., Elmets C.A., Agarwal R., et al. Protection against ultraviolet-B radiation-induced local and systemic suppression of contact hypersensitivity and edema responses in C3H/HeN mice by green tea polyphenols. Photochem Photobiol 1995, 62:855-861.
25. Gehring W. Nicotinic acid/niacinamide and the skin. J Cosmet Dermatol 2004, 3:88-93.
26. Bissett D.L., Oblong J.E., Berge C.A. Niacinamide: a B vitamin that improves aging facial skin appearance. Dermatol Surg 2005, 31(7 Pt 2):860-865.
27. Kligman A.M., Grove G.L., Hirose R., et al. Topical tretinoin for photoaged skin. J Am Acad Dermatol 1986, 15:836-859.
28. Griffiths C.E., Russman A.N., Majmudar G., et al. Restoration of collagen formation in photodamaged human skin by tretinoin (retinoic acid). N Engl J Med 1993, 329:530-535.
29. Fisher G.J., Datta S., Wang Z., et al. c-Jun-dependent inhibition of cutaneous procollagen transcription following ultraviolet irradiation is reversed by all-trans retinoic acid. J Clin Invest 2000, 106:663-670.
30. Fisher G.J., Tavakkol A., Griffiths C.E., et al. Differential modulation of transforming growth factor-beta 1 expression and mucin deposition by retinoic acid and sodium lauryl sulfate in human skin. J Invest Dermatol 1992, 98:102-108.
31. Fisher G.J., Datta S.C., Talwar H.S., et al. Molecular basis of sun-induced premature skin aging and retinoid antagonism. Nature 1996, 379:335-339.
32. Fisher G.J., Wang Z.Q., Datta S.C., et al. Pathophysiology of premature skin aging induced by ultraviolet light. N Engl J Med 1997, 337:1419-1428.
33. Kang S. Photoaging and tretinoin. Dermatol Clin 1998, 16:357-364.
34. Orlow S.J., Chakraborty A.K., Pawelek J.M. Retinoic acid is a potent inhibitor of inducible pigmentation in murine and hamster melanoma cell lines. J Invest Dermatol 1990, 16:357-364.
35. Griffiths C.E., Finkel L.J., Tranfaglia M.G., et al. An in vivo experimental model for effects of topical retinoic acid in human skin. Br J Dermatol 1993, 129:389-394.
36. Kang S., Duell E.A., Fisher G.J., et al. Application of retinol to human skin in vivo induces epidermal hyperplasia and cellular retinoid binding proteins characteristic of retinoic acid but without measurable retinoic acid levels or irritation. J Invest Dermatol 1995, 105:549-556.
37. Diridollou S., Vienne M.P., Alibert M., et al. Efficacy of topical 0.05% retinaldehyde in skin aging by ultrasound and rheological techniques. Dermatology 1999, 199(Suppl 1):37-41.
38. Saurat J.H., Didierjean L., Masgrau E., et al. Topical retinaldehyde on human skin: biologic effects and tolerance. J Invest Dermatol 1994, 103:770-774.
39. West M.D. The cellular and molecular biology of skin aging. Arch Dermatol 1994, 130:87-95.
40. Chung J.H., Seo J.Y., CHoi H.R., et al. Modulation of skin collagen metabolism in aged and photoaged human skin in vivo. J Invest Dermatol 2001, 117:1218-1224.
41. Varoni J., Spearman D., Perone P., et al. Inhibition of type I procollagen synthesis by damaged collagen in photoaged skin and by collagenase-degraded collagen in vitro. Am J Pathol 2001, 158:931-942.
42. Ohniski Y., Tajima S., Akiyama M., et al. Expression of elastin-related proteins and matrix metalloproteinases in actinic elastosis of sun-damaged skin. Arch Dermatol Res 2000, 292:27-31.
43. Brennan M., Bhotti H., Nerusu K.C., et al. Matrix metalloproteinase-1 is the major collagenolytic enzyme responsible for collagen damage in UV-irradiated human skin. Photochem Photobiol 2003, 78:43-48.
44. Katayama K., Armendariz-Borunda J., Raghow R., et al. A pentapeptide from type I procollagen promotes extracellular matrix production. J Biol Chem 1993, 268:9941-9944.
45. Pickart L., Freedman J.H., Loher W.J., et al. Growth-modulating plasma tripeptide may function by facilitating copper uptake into cells. Nature 1980, 288:715-717.
46. 2+. FEBS Lett 1988, 238:343-346.
47. 2+stimulates matrix metalloproteinase-2 expression by fibroblast cultures. Life Sci 2000, 67:2257-2265.
48. 2+. J Invest Dermatol 2000, 115:962-968.
49. 2+. Life Sci 1992, 51:1049-1056.
50. Blanes-Mira C., Clemente J., Jodas G., et al. A synthetic hexapeptide (argireline) with antiwrinkle activity. Int J Cosmet Sci 2002, 24:303-310.
51. Sundaram H., Mehta R., Norine J., et al. Role of physiologically balanced growth factors in skin rejuvenation. J Drugs Dermatol 2009, 8(Suppl 5):1-16.
52. Mehta R.C., Smith S.R., Grove G.L., et al. Reduction in facial photodamage by a topical growth factor product. J Drugs Dermatol 2008, 7(9):864-871.
53. Abad R.F. Treatment of experimental radiodermatitis with a regenerative glucoproteic mucomucopolysaccharide complex. Dermatol Cosmet 1999, 9:53-57.
54. Brieva A., Philips N., Tejedor R., et al. Molecular basis for the regenerative properties of a secretion of the mollusk cryptomphalus aspersa. Skin Pharmacol Physiol 2008, 21:15-22.
55. Tribo-Boixareu M.J., Parrado-Romero C., Badr R., et al. Clinical and histological efficacy of a secretion of the mollusk Cryptomphalus aspersa in the treatment of cutaneous photoaging. Cosmetic Dermatol 2009, 22(5):247-252.
56. Yarosh D. Cyclobutane pyrimidine dimer removal enhanced by DNA repair liposomes reduces the incidence of UV skin cancer in mice. Cancer Res 1992, 52:4227-4237.
57. Yarosh D. The new science of perfect skin 2008, Broadway Books, New York.
58. Brychtova S., Bezdekova M., Brychta T., et al. The role of vascular endothelial growth factors and their receptors in malignant melanomas. Neoplasma 2008, 55(4):273-279.
59. Mehnert J.M., McCarthy M.M., Jilaveanu L., et al. Quantitative expression of VEGF, VEGF-R1, VEGF-R2, and VEGF-R3 in melanoma tissue microarrays. Hum Pathol 2010, 41(3):375-384.
60. Liu B., Earl H.M., Baban D., et al. Melanoma cell lines express VEGF receptor and respond to exogenously added VEGF. Biochem Biophys Res Commun 1995, 217:721-727.
61. Benjamin L.E., Keshet E. Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. Proc Natl Acad Sci U S A 1997, 94:8761-8766.
62. McMahon G. VEGF receptor signaling in tumor angiogenesis. Oncologist 2000, 5(Suppl 1):3-10.
63. Alam M., Ratner D. Cutaneous squamous cell carcinoma. N Engl J Med 2001, 344:975-983.
64. Lobo M., Shimino Y., Qian D., et al. The biology of cancer stem cells. Annu Rev Dev Biol 2007, 23:675-699.
65. Ellis L.M., Hicklin D.J. VEGF-targeted therapy: mechanisms of anti-tumor activity. Nat Rev Cancer 2008, 8:579-591.
66. Perez-Losada J., Balmain A. A stem-cell hierarchy in skin cancer. Nat Rev Cancer 2003, 3:434-443.
67. Beck B., Driessens G., Goossens S. A vascular niche and a VEGF-Nrp1 loop regulate the initiation and stemness of skin tumors. Nature 2011, 478:399-403. 10.1038/nature10525.
68. Dong W., Yi L., Gao M., et al. IKKα contributes to UVB-induced VEGF expression by regulating AP-1 transactivation. Nucleic Acids Res 2011, [Epub ahead of print]. 10.1093/nar/gkr1216.
69. Balkishran R., McMichael A.J., Camacho P.T., et al. Development and validation of a health-related quality of life instrument for women with melasma. Br J Dermatol 2003, 149:572-577.
70. Roh M.R., Chung K.Y. Infraorbital dark circles: definition, causes, and treatment options. Dermatol Surg 2009, 35:1163-1171.
71. Lowe N.J., Wieder J.M., Shorr N., et al. Infraorbital pigmented skin. Preliminary observations of laser therapy. Dermatol Surg 1995, 21:767-770.
72. Hori Y., Takayama O. Circumscribed dermal melanoses. Classification and histologic features. Dermatol Clin 1988, 6:315-326.
73. Sun C.C., Lu Y.C., Lee E.F., et al. Naevus fusco-caeruleus zygomaticus. Br J Dermatol 1987, 117:545-553.
74. Newcomer V.D., Lindberg M.C., Sternberg T.H. A meanosis of the face (" chloasma" ). Arch Dermatol 1961, 83:284-299.
75. Epstein J.S. Management of infraorbital dark circles. A significant cosmetic concern. Arch Facial Plast Surg 1999, 1:303-307.
76. Kurban R.S., Bhawan J. Histologic changes in the skin associated with aging. J Dermatol Surg Oncol 1990, 16:908-914.
77. Goldberg R.A., McCann J.D., Fiaschetti D., et al. What causes eyelid bags? Analysis of 114 consecutive patients. Plast Reconstr Surg 2005, 115:1395-1402.
78. Kane M.A. Treatment of tear trough deformity and lower lid bowing with injectable hyaluronic acid. Aesthetic Plast Surg 2005, 29:363-367.
79. Cohen J.L. Enhancing the growth of natural eyelashes. The mechanism of bimatoprost-induced eyelash growth. Dermatol Surg 2010, 36:1361-1371.
80. Woodward J.A., Haggerty C.J., Stinnett S.S., et al. Bimatoprost 0.03% gel for cosmetic eyelash growth and enhancement. J Cosmet Dermatol 2010, 9:96-102.
81. Yoelin S., Walt T.G., Earl M. Safety, effectiveness and subjective experience with topical bimatoprost 0.03% for eyelash growth. Dermatol Surg 2010, 36:638-649.
82. Elias M.J., Weiss J., Weiss E. Bimatoprost ophthalmic solution 0.03% for eyebrow growth. Dermatol Surg 2011, 37:1057-1059.